A Prospective Study Comparing the Accuracy of Olympus Lucera Spectrum Technology vs Olympus Lucera Elite Technology in the in Vivo Diagnosis of Barrett's Oesophagus and Colorectal Polyps: The ELITE Study

计划入组 232 人 · 首次发布于 2017 年 3 月 8 日

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects

计划入组 37 人 · 首次发布于 2016 年 10 月 26 日

A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects

计划入组 39 人 · 首次发布于 2016 年 10 月 26 日

Lucerastat

C₁₀H₂₁NO₄

Sulfoxazine maleate

ATPase modulator (Lycera)

Lycera Corp.

United States

ANKUR LUTHRA

Australia

LUMARA HEALTH INC

United States

TechBio Company Lucera Launches with AI-Powered Platform to Transform Pharmaceutical R&D Decision-Making

Dyne Therapeutics Strengthens Leadership Team with Key Scientific and Business Appointments

Lucerastat Demonstrates Significant Efficacy in Phase 3 Trial for Fabry Disease Treatment